This inventor holds 1 USPTO granted patent. Top assignee: Molecular Genetics, Inc.. Active years: 1987.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1987
Title: John H. Weis: Innovator in Reverse Transcriptase Production
Introduction
John H. Weis is a notable inventor based in Minneapolis, MN (US). He has made significant contributions to the field of molecular genetics, particularly in the production of reverse transcriptase. His innovative work has implications for various applications in biotechnology and genetic research.
Latest Patents
John H. Weis holds a patent for the production of reverse transcriptase. The patent describes methods for producing the β-subunit of reverse transcriptase using recombinant DNA techniques. It outlines methods and compositions for cloning and expressing the gene coding for the β-subunit of reverse transcriptase, as well as characterizing and isolating the gene product. The recombinant plasmids constructed in this work contain the necessary signals and controls for efficient expression of the reverse transcriptase gene in bacteria and other microorganisms. The isolated reverse transcriptase gene product is a functional, metabolically stable, and biologically active protein. He has 1 patent to his name.
Career Highlights
John H. Weis is associated with Molecular Genetics, Inc., where he has contributed to advancing genetic research and biotechnology. His work has been instrumental in enhancing the understanding and production of essential proteins in the field.
Collaborations
John H. Weis has worked alongside John S. Salstrom, contributing to the innovative projects at Molecular Genetics, Inc. Their collaboration has fostered advancements in genetic engineering and molecular biology.
Conclusion
John H. Weis is a prominent figure in the field of molecular genetics, with a focus on reverse transcriptase production. His innovative approaches and contributions continue to impact the biotechnology landscape.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile